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Inherited retinal diseases (IRDs) represent a clinical and genetic heterogeneous group of
chorioretinal disorders. The frequency of persons affected by an IRD due to mutations in the
same gene varies from 1 in 10,000 to less than 1 in a million. To perform meaningful
genotype-phenotype analyses for rare genetic conditions, it is necessary to collect data from
sizable populations. Although several standardized functional tests are used widely,
ophthalmologic data usually are stored in local databases and not in multicenter databases
that are linked with other centers. To be able to register ophthalmologic data of all Dutch
patients with IRDs into one database, we developed the RD5000 database (RD5000db), which
can harbor all ophthalmologic and selected genetic data. Authorization rights for the
management, data entry, and data sharing have been set up, rendering this database into a
user-friendly, secure, and widely used repository that will facilitate future studies into
molecular genetics and therapies for IRDs. The RD5000db database has the potential to grow
into a European standard for the registration of data from IRDs.
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Inherited retinal diseases (IRDs) constitute a clinicallyheterogeneous group of disorders that involve degeneration
of the photoreceptors, RPE, and/or choroid.1–4 The incidence
rates vary from 1 in 10,000 (for Stargardt disease) to less than 1
in a million for rare clinical subtypes.5–9 The diseases affect
both sexes, and include major causes of blindness in children
and young adults worldwide, although some patients remain
asymptomatic until middle-age. The phenotypic variability is
caused by genetic defects in a large number of genes. In the last
25 years, over 200 genes associated with syndromic and
nonsyndromic IRDs (RetNet, available in the public domain at
https://sph.uth.edu/retnet/) were identified.4,10,11
The internet offers several public and license-protected
databases that contain genetic data on IRDs, such as the Leiden
Open (source) Variation Databases (LOVDs, available in the
public domain at http://www.lovd.nl/3.0/home), the Human
Gene Mutation Database (HGMD, available in the public
domain at http://www.hgmd.org/), and the retina international
mutation database (available in the public domain at http://
www.re t ina - in te rna t iona l .o rg / sc i -news/da tabases /
mutation-database/). Still, databases containing clinical data are,
to our knowledge, not publically available. Instead, most
specialized medical centers use a database exclusively accessi-
ble by that specific center. This lack of publically available
clinical data most likely is due to privacy legislation and medical
ethics. On the other hand, there are websites that provide an
overview of genetic and clinical features of IRDs published in
the literature, such as the Retinal Network (RetNet, available in
the public domain at https://sph.uth.edu/retnet/) and the
Online Mendelian Inheritance in Man (OMIM, available in the
public domain at http://www.omim.org/).
Since incidence rates are low in IRDs, national collabora-
tions are the first step to get an overview of cohort sizes, the
distribution of certain genetic defects, and the matching clinical
features. This also will be important to identify persons for
(gene) specific therapeutic trials. In this light, 11 Dutch
ophthalmic centers collaborated in a project, named RD5000,
to set up a database with anonymized clinical and genetic data:
the RD5000 database (RD5000db, available in the public
domain for members at http://www.RD5000db.nl). The name
‘‘RD5000’’ was based on the estimated prevalence of 5000
patients with inherited retinal diseases in the Netherlands. To
obtain larger cohort sizes for studies on specific genotypes,
phenotypes, or genotype-phenotype correlations, international
expansion of the database is possible and desirable.
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OBJECTIVES OF THE RD5000 DATABASE
To our knowledge, the RD5000db is the first multicentered,
web-based database available in the field of inherited retinal
diseases. Main objectives are standardization of clinical and
genetic data registration, pseudo-anonymized (‘‘pseudomized’’)
storage of data, and web-based, controlled data sharing among
participating medical centers. The pseudomized character of
the data storage lies in the absence of personal characteristics
that could lead to the identification of a specific patient, and
the presence of a center-specific internal patient identification
number. This results in anonymized data for the centers that
have access to the database, and personalized data for the
patient’s medical center that also owns the source data files.
Data Access by other centers is controlled; only a few general
features are available commonly in a ‘‘catalogue.’’ Access to all
other details can be granted either for clinical reasons (e.g.,
when the patient attends an ophthalmologist or geneticist in
another center participating in RD5000db) or research reasons
(e.g., for a specific research question; see Data Access below).
This controlled access allows the professionals to be in charge
of the data to be shared.
DATABASE DESIGN
We reviewed literature on existing databases in the field of
ophthalmic retinal disease. The Ophthabase database (used in
Tuebingen, Germany) was used for database structure and lay-
out.12 Additionally, the biobank of the string-of-pearls initiative
(The Netherlands, Dutch: Parelsnoer initiatief) was used for
their way of structuring multicenter data entry and access to
patient data (see Data Access).13 Additionally, jurisdiction and
expert opinion on national privacy legislation and patient data
were obtained.
Source Code
The source code of Ophthabase (developed by Institute for
Ophthalmic Research, Tu¨bingen, Germany, as part of the EVI-
GENORET Project) was generously provided for further
development. The HTML design and data model of Ophthabase
were used as a starting point for RD5000db and were altered to
the specifications of RD5000db by the company First8
(available in the public domain at www.first8.com). The
RD5000db is built in Java 1.7 (Oracle Corporation, Redwood
Shores, CA, USA) and runs on an Apache Tomcat 7.0 (The
Apache Software Foundation, Forest Hill, MD, USA) application
server, and uses PostgreSQL 8.4 (EnterpriseDB Corporation,
Bedfort, MA, USA) as a relational database. The web interface is
built using Apache Wicket 6 (The Apache Software Founda-
tion) and uses Spring Core (Pivotal Software, Palo Alto, CA,
USA) framework to interact with services, which contain the
business logic. Hibernate (Red Hat, Inc., Raleigh, NC, USA),
which implements the Java Persistence application program-
ming interface 2 standard, is used to query the database. Spring
Security (Pivotal Software) is used for authorization and
authentication, and is used to implement the roles and rights
system. Access from the web always is redirected from http to
https, which uses Secure Socket Layer (SSL) to ensure
encrypted transportation of the data over the internet.
Data Entry
The RD5000db is set up as a research database that contains
pseudomized patient data. The internal IDs are used to relate
the data stored in RD5000db to information in the medical files
of the centers in which the patient is treated (pseudomization).
Although no personal data that could identify a patient are
stored in the database, initials, date of birth, and sex are
entered to construct a hash code that is used to identify double
entries. Since only the hash code is stored, the initials and date
of birth are not accessible, but the year of birth and sex remain
visible to users.
The data forms are organized around the pseudomized Basic
Patient Data (Supplementary Fig. S1B). The structure of
RD5000db was based on the case report form (CRF) and
standard operative procedures (SOPs) that were formulated by
the RD5000 consortium, as well as on the data structure of
Ophthabase. We designed five different data forms: patient
history, genetics/DNA sample, clinical examinations, technical
examinations, and diagnoses forms. More details on the
different data entry forms are provided in the Supplementary
Appendix S1 and Supplementary Figures S1A through S1G.
Numerous clinical and technical examinations can be entered
when follow-up data (longitudinal data) are available. Further-
more, image files of imaging techniques or examination reports
can be uploaded to support the clinical data. The database
allows patients to be registered in multiple centers that all can
contribute to the data volume of a single the patient (Fig. 1),
which is not uncommon in The Netherlands. Family data are
entered initially in the family history section of the history form
(see Supplementary Appendix S1). These data only include the
number of affected individuals within the family, their relation
to the patient and (if available) internal registration numbers of
the parents. However, RD5000db provides the ability to assign
family members that are entered in the database to a family ID
in the Family tab (Supplementary Fig. S2).
Informed Consent
We endeavored to enroll patients in the RD5000db with their
approval to adhere to the tenets of the Declaration of Helsinki,
although the data entered in the database are pseudomized and
patient’s personal details are available only to the center the
patient attends (via the internal ID), which makes informed
consent not obligatory. Nevertheless, we created an informed
consent to obtain patient approval for data entry in the
database.
FIGURE 1. Visualization of data access in case patient data are entered
from one, two, or three centers. The numbers indicate the number of
centers that have access to the patient’s data. If more than three
centers are involved, the principle is followed analogously.
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Privacy
Due to the sensitive nature of the collected data we carefully
considered how to handle privacy correctly according to the
Dutch privacy regulations. At first the idea was to encrypt all
the data using a public key infrastructure (PKI). In this set-up,
only the super administrator of RD5000db would have access
to the private key. However, in this approach maintenance by
our hosting provider or ICT implementation party would be
complicated. Therefore, the data were anonymized in such a
way that it is not possible to directly identify a patient.
However, the center that a patient attends can identify the
patient by means of a separate registration system that is not
connected in any physical or electronic way to the RD5000db
application. In the RD5000db, this is possible by the internal
ID that is linked to a patient in that specific center; hence, only
members of that center can acquire the patient’s privacy-
sensitive details from their own center’s registration systems.
Only a very limited amount of information is available to
members of the other centers with access to the RD5000db.
They can, however, obtain additional anonymous patient data
upon permission from the review committee (see Data
Access).
Identifying Double Entries
We introduced a hash code based on date of birth, initials, and
sex to prevent double entry of a patient. However, this
procedure has its limitations: initials are not always completely
registered in the hospital’s registration systems and, in some
cases, names may be noted incorrectly on the medical files. For
some individuals the distinction between first and family
names is not clear, resulting in a different order of the initials
that constructs a different hash code. Preventing double entry,
however, is important, especially in these small groups of
patients. When a double entry is suspected, the system
administrator executes an audit trail based on year of birth,
sex, and diagnosis, and verifies personal details of the
presumed double entries with the responsible physicians
(who generally are from two different centers), before merging
the entries.
Search Engines
The RD5000db includes two search engines to explore patient
data: the search engine of the database located on the
Catalogue tab that searches all entries, and the search engine
on the Patients tab that searches only patients accessible to the
user (Supplementary Figs. S3A, S3B). Both search engines are
identical in composition, but differ in function. The Catalogue
tab presents a limited set of data for all patients in the database,
allowing the users to have an indication of the population that
has been entered in RD5000db. This information can be used
for formulating a research question and obtaining data access
to other patients, the procedure of which is elaborated below
(see Data Access). The search function in the Patients tab
provides the full data of the patients entered by the user’s
center, or of the patients the user has obtained access to.
Authorization Roles
The hierarchy in authorization roles in RD5000db involves one
system administrator, who has access to all data and roles of all
users database-wide, and multiple center administrators, who
have access to all data and roles of users in their center. Each
center has two additional roles available: writers, who can
read, edit, and add data to patients of their center, as well as
add patients to the database, and readers, who have read-only
access to data from patients of their center. The reader and
writer roles can be assigned to multiple users.
The system administrator has the main supervising role in
the system, which includes organizational tasks, including add/
delete roles of center administrators, handle requests to delete
patients from the database, merge patient’s data in case of
multiple entries of a single patient, change access rights per
patient per form, and search all patients (see Data Access). The
center administrator has the supervising role within a center
and takes care of communication to the system administrator,
provides help to the users in his center, adds and removes
users, and changes user roles of his center, and provides
passwords to users within the center.
Data Access
The database is available in the public domain at https://www.
RD5000db.nl. To register for the database, the registration form
must be completed, including a specific center key (provided
by the center administrator). After registration, a password will
be sent to the user, to log into RD5000db and access patient
data. By default, the user has access to all the patients linked to
its own center. Which actions the user can perform depends
on the role assigned to him (see Authorization Roles).
Patients linked to two or more centers can be accessed by
each of these centers (Fig. 1). Regulations on data management
state that one center does not alter data entered by another
center. Since technical and clinical examinations are stored as
separate files for different time points, additional data can be
added easily. Violations are tracked in the audit trails (see Audit
Logging). When a patient with initials, date of birth, and sex
identical to an existing entry is entered into the database, users
receive the double entry notification. After verification of the
patient details, the system administrator can assign the patient
to both centers.
For specific research questions, an RD5000db-user can
receive access to the data of patients of other centers by
formulating a research question application for the RD5000db
review committee (Fig. 2). The RD5000db review committee
consists of RD5000-members, one of each participating center.
A positive decision from this committee enables the system
administrator to grant the researcher access to the requested
data (Fig. 2). The access granted can be specified up to the
level of specific forms (without access to the data on other
forms of this patient). This same procedure is applicable in
case an external researcher would wish to have data from the
RD5000db. The only difference is that in case the request is
granted, data are sent in an export file to the external
researcher instead of granting access to the database.
Data Export
Patient data can be exported in two forms. Firstly, each single
form can be exported in PDF format and can be stored in
patient’s medical files if desired. Secondly, in the Reporting tab
patient data can be exported to a Windows Excel 2007
Worksheet format (.xslx; Microsoft Corporation, Redmond,
WA, USA), which enables further data analyses by various
statistical programs. The Excel export file includes the data of
all patients to which the user has access. Any filtering of the
data should be done after data export. The variables are
organized in separate tabs of the worksheet based on the forms
of the database. In each tab, the data are arranged based on
RD5000 ID. Longitudinal data, such as clinical and technical
examination data of multiple visits, are presented in a single
row per examination, each identified with the RD5000 ID and
the examination date. Where value lists are used in the
database, numeric values are present in the export worksheet,
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which can be identified using the codebook with the
corresponding labels that are available in the last tab of the
worksheet.
An SPSS syntax document was written to simplify data
import and management in SPSS (available in the public
domain for RD5000 members at http://www.RD5000.nl). By
running the syntax, the data of all Excel worksheet tabs are
imported into SPSS synthesizing one entry with correct
labeling and subheadings. The syntax files are structured with
subheadings, which enables selective use of parts of the syntax
code.
Audit Logging
All actions (inserts, updates and deletes) toward the database
are stored in an audit log (also in the database). With this audit
log, a registration is made that includes the details of the
FIGURE 2. Flowchart on the process to request access to data. Each center in principle only has access to the data entered by their own center.
Colleagues from other centers obtain access to the data from other centers only after approval by a review committee, which contains
representatives of all data-contributing centers. External researchers can only obtain data through this review committee. Upon authorization, the
system administrator will give internal researchers access to the data, and provide the requested data to the external researchers in a report file.
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specific user, the time of the action, as well as the details of the
actions. These details can be retrieved upon request.
CURRENT STATUS AND USABILITY OF THE RD5000
DATABASE
The RD5000db was launched online at September 1, 2012. In
the meantime, 1923 patients with retinal dystrophies have
been registered in the database (reference date June 1, 2014),
with a mean age of 41 years (range, 1–102 years). In this
cohort, 62 different diagnoses were made based on clinical
phenotype and inheritance pattern. Clinical and/or technical
examinations were registered for 469 patients (24.3%) with an
average number of visits of 4.5 (range, 1–17 for technical
examinations and 1–22 for clinical examinations). Follow-up
periods varied between 0 and 51 years. The DNA samples were
available for 1235 patients (64.2%). Of these, 684 patients
(35.6% of all entries) were solved genetically, and 188
additional patients (9.8% of all entries) carried putatively
causative mutations, but have not yet been solved completely.
Causative or putatively causative mutations were found in 77
different genes.
Time needed for entry of one patient is dependent mainly
on the source data and the amount of details to be entered.
Initially, comprehensive data entry takes up to 40 minutes per
patient on average. However, for a trained person this time may
be reduced to a maximum of 25 minutes for a full data record.
FUTURE PLANS
Data Quality Surveillance
In the near future, we will cope with some of the problems we
encountered in the past two years. One issue of high priority is
the double entry check that is intended to prevent the repeated
entry of a patient. The current hash code that combines the
patient’s initials, date of birth, and sex has proven to be
insufficiently solid, since we found 11 double entries up to
now in 1923 records. The entry of the initials has shown to be the
most variable and inconsistent factor, since registrations in
hospitals often are incomplete or incorrect. A solution may be the
entry of a citizen identification number (Dutch: Burger Service
Nummer, BSN) using Trusted Third Party (TTP) procedures,
which warrants pseudomization that complies with the strictest
privacy legislations. Furthermore, standard procedures for
checking data quality will be written, thereby preventing errors
in the data entry, such as misspelled gene names and other free
text fields. Finally, there currently is no compulsory minimal
clinical dataset, which may be very useful for several research
questions that rely on detailed clinical data. However, the data
requirements will be different for each research question,
complicating the definition of the minimal dataset.
Funding
Up to now, the costs for the development of RD5000db have
been covered by Dutch blindness foundations. However, once
the database is used routinely, it stands to reason that each
participating center contributes an annual fee to host,
maintain, and update the database. Information about the set-
up and maintenance costs for the database can be found in
Supplementary Appendix S2.
International Expansion of the Database
Currently, the RD5000db is available for 11 Dutch ophthalmo-
logic centers. In the near future, we want to include data of a
few international centers. The RD5000db thereby has the
potential to develop into a pan-European database for the
detailed registration of clinical data. By increasing the number
of patient records, its potential will grow significantly and
facilitate many different studies in the fields of genetics,
genotype-phenotype comparisons, and the application of novel
therapies.
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